ポスト
This randomized, noninferiority trial compared ketamine with electroconvulsive therapy (ECT) in treatment-resistant depression. Ketamine was noninferior to ECT for treatment-resistant depression without psychosis (ELEKT-D trial). https://t.co/fTjEfcbgMt #APAAM23
メニューを開く